Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study

INTRODUCTION: Pyrotinib plus capecitabine has been approved in China for human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC). Meanwhile, vinorelbine is another important chemotherapy option for MBC available in oral and intravenous forms. Thus, pyrotinib plus vino...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi, Qiu, Yixuan, Li, Huihui, Luo, Ting, Li, Wei, Wang, Hong, Shao, Bin, Wang, Biyun, Ge, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120312/
https://www.ncbi.nlm.nih.gov/pubmed/33996589
http://dx.doi.org/10.3389/fonc.2021.664429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120312/
https://www.ncbi.nlm.nih.gov/pubmed/33996589
http://dx.doi.org/10.3389/fonc.2021.664429

Ejemplares similares